KR100299306B1 - Lactic acid bacteria with high acid resistance and growth rate and excellent blood cholesterol lowering ability - Google Patents
Lactic acid bacteria with high acid resistance and growth rate and excellent blood cholesterol lowering ability Download PDFInfo
- Publication number
- KR100299306B1 KR100299306B1 KR1019980027045A KR19980027045A KR100299306B1 KR 100299306 B1 KR100299306 B1 KR 100299306B1 KR 1019980027045 A KR1019980027045 A KR 1019980027045A KR 19980027045 A KR19980027045 A KR 19980027045A KR 100299306 B1 KR100299306 B1 KR 100299306B1
- Authority
- KR
- South Korea
- Prior art keywords
- strain
- present
- acid resistance
- lactic acid
- growth rate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/23—Lactobacillus acidophilus
Abstract
본 발명은, 건강한 한국 성인의 분변에서 분리한 내산성, 담즙산 내성 및 혈중 콜레스테롤 저하능이 우수하고 생장 속도가 빠른 젖산균인 락토바실러스 애시도필러스 SNUL 01균주에 관한 것으로, 본 발명의 균주는 내산성과 담즙산 내성 및 혈중 콜레스테롤 저하와 관련된 특성이 우수하고 생장속도가 빠르기 때문에, 본 발명의 균주는 소화기관에서의 생존율이 높으며, 특히 본 발명의 균주는 건강한 한국 성인의 생체에서 분리한 것이어서 한국인의 장내 정착할 가능성이 높다. 그러므로, 본 발명의 균주 또는 균주를 배양한 배양물이나 발효식품을 식음용하였을 때, 정장 효과 및 콜레스테롤 저하 효과를 기대할 수 있다.The present invention relates to Lactobacillus ashdophilus SNUL 01 strain, which is excellent in acid resistance, bile acid resistance, blood cholesterol lowering ability and fast growth rate isolated from feces of healthy Korean adults, and the strain of the present invention is acid resistant and bile acid. Because of excellent properties related to resistance and lowering blood cholesterol and fast growth rate, the strain of the present invention has a high survival rate in the digestive organs, and in particular, the strain of the present invention has been isolated from living organisms of healthy Korean adults and thus can be established in Korean intestines. Most likely. Therefore, when the culture or fermented food cultured strain or strain of the present invention can be eaten, it can be expected to have a formal effect and cholesterol lowering effect.
Description
본 발명은 내산성 및 담즙산 내성이 우수하여 인체의 소화 장기에서의 생존력이 탁월하고, 혈중 콜레스테롤 저하능력이 우수하며, 생장속도가 빠른 새로운 젖산균에 관한 것으로, 더욱 상세하게는 상술한 우수한 특성을 나타내는 락토바실러스 애시도필러스에 관한 것이다.The present invention relates to a new lactic acid bacterium having excellent acid resistance and bile acid resistance, excellent viability in the digestive organs of the human body, excellent blood cholesterol lowering ability, and fast growth rate, and more particularly, lactose exhibiting the above-described excellent characteristics. It relates to Bacillus ashdophyllus.
젖산균은 동물의 장내에 분포하여 유해 미생물 성장의 억제, 이상 발효의 치료, 혈중 콜레스테롤 저하, 면역 기능의 증진 등의 효과를 나타내며, 항암 작용도 있는 것으로 보고되고 있다.Lactic acid bacteria are distributed in the intestines of animals, have the effect of inhibiting the growth of harmful microorganisms, treatment of abnormal fermentation, lowering blood cholesterol, enhancing immune function, and also have anti-cancer effects.
이러한 젖산균을 사람이 섭취하여 건강을 증진할 수 있도록 발효 유제품이 상용화되어 널리 음용 또는 식용되고 있다. 발효 유제품에 사용되는 대표적인 균주로는 락토바실러스 애시도필러스(L. acidophilus), 락토바실러스 카세이(L. casei), 락토바실러스 불가리쿠스(L. bulgaricus), 스트렙토코커스 써모필러스(Str. thermophilus) 등이 있다.Fermented dairy products are commercialized and widely consumed or edible so that humans can ingest these lactic acid bacteria to promote their health. Representative strains used in fermented dairy products are L. acidophilus, Lactobacillus casei, L. bulgaricus, Streptococcus thermophilus Etc.
젖산균이 인체에 유용한 효과를 나타내려면 소화기관을 통과하는 과정에서 생존하여 소장에 정착할 수 있어야 한다. 따라서, 위장에서 분비되는 산과 소장에서 분비되는 담즙산에 대한 내성이 높을수록 젖산균이 이들 소화기관의 가혹한 환경에서 생존하여 소장에 도달하는 생균수가 많아지기 때문에, 이러한 성질을 갖는 젖산균을 사용하여 발효제품을 제조하였을 때 실질적으로 인체에 유용한 기능을 할 수 있는 것이다.For lactic acid bacteria to have a beneficial effect on the human body, it must be able to survive the passage through the digestive tract and settle in the small intestine. Therefore, the higher resistance to acid secreted from the stomach and bile acids secreted from the small intestine increases the number of viable bacteria that survive in the harsh environment of these digestive tracts and reach the small intestine. When manufactured, it can function substantially useful to the human body.
그러므로, 발효 유제품에 사용되는 젖산균에 요구되는 성질로서 내산성 및 담즙산 내성이 중요한 문제가 되어 왔으며, 이러한 특성이 우수한 균주를 분리, 개발하려는 노력이 다각도로 시도되고 있다.Therefore, acid resistance and bile acid resistance have become important issues as properties required for lactic acid bacteria used in fermented dairy products, and various efforts have been made to isolate and develop strains having excellent characteristics.
한편, 젖산균이 지속적으로 유용한 기능을 하기 위해서는 상술한 내산성 및 담즙산 내성 이외에 장내에서의 정착율이 높아야 한다. 그러나, 젖산균은 숙주 특이성을 나타내기 때문에, 사람을 위한 발효제품을 위해서는 사람으로부터 분리한 젖산균이 실제로 인체내에 정착하여야 소기의 효과를 얻을 수 있다.On the other hand, in order for the lactic acid bacteria to have a continuous useful function, in addition to the acid resistance and bile acid resistance described above, the intestinal fixation rate should be high. However, since lactic acid bacteria exhibit host specificity, for fermentation products for humans, lactic acid bacteria isolated from humans should actually settle in the human body to obtain desired effects.
또한, 젖산균은 현대인의 성인병, 특히 순환계 계통의 질환에 유해한 것으로 알려진 혈중콜레스테롤을 저하시키는 효과도 있기 때문에, 이러한 특성이 우수한 젖산균을 개발하는 것이 요구되고 있다.In addition, since lactic acid bacteria also have an effect of lowering blood cholesterol, which is known to be harmful to adult diseases of humans, in particular, diseases of the circulatory system, it is required to develop lactic acid bacteria having excellent characteristics.
따라서, 본 발명의 목적은, 내산성 및 담즙산 내성이 높고 생장속도가 빠르며, 인체의 혈액내 콜레스테롤을 저하시키는 능력이 우수한 새로운 젖산균을 제공하는 것이다.Accordingly, an object of the present invention is to provide a new lactic acid bacterium having high acid resistance and bile acid resistance, fast growth rate, and excellent ability to lower cholesterol in the blood of the human body.
본 발명의 다른 목적은, 인체에 섭취되었을 때 유용한 특성을 나타내는 락토바실러스 애시도필러스(락토바실러스 애시도필러스 SNUL 01)을 제공하는 것이다.Another object of the present invention is to provide Lactobacillus ashidophilus (Lactobacillus ashidophyllus SNUL 01), which exhibits useful properties when ingested in the human body.
본 발명의 또다른 목적은, 한국인에 적합한 새로운 젖산균을 제공하는 것이다.Another object of the present invention is to provide a new lactic acid bacteria suitable for Koreans.
본 발명의 또다른 목적은, 락토바실러스 애시도필러스 SNUL 01을 이용하여 제조한 발효제품을 제공하는 것이다.Another object of the present invention is to provide a fermentation product prepared using Lactobacillus ashidophilus SNUL 01.
본 발명의 또다른 목적은, 락토바실러스 애시도필러스 SNUL 01을 이용하여 제조한 정장제를 제공하는 것이다.Another object of the present invention is to provide a formal preparation prepared using Lactobacillus ashidophilus SNUL 01.
도 1은 실시예 1과 비교예 1 및 2의 내산성 시험(1)의 결과를 보인 그래프,1 is a graph showing the results of the acid resistance test (1) of Example 1 and Comparative Examples 1 and 2,
도 2는 실시예 2와 비교예 3 내지 5의 내산성 시험(2)의 결과를 보인 그래프,2 is a graph showing the results of the acid resistance test (2) of Example 2 and Comparative Examples 3 to 5,
도 3a 내지 도 3d는 실시예 3과 비교예 6 내지 8의 담즙산 내성 시험의 결과를 보인 그래프,3A to 3D are graphs showing the results of the bile acid resistance test of Example 3 and Comparative Examples 6 to 8,
도 4는 실시예 5와 비교예 12 내지 14의 생장 시험의 결과를 보인 그래프,Figure 4 is a graph showing the results of the growth test of Example 5 and Comparative Examples 12 to 14,
도 5는 실시예 6가 비교예 15의 탈지유에서의 생장 시험의 결과를 보인 그래프.Figure 5 is a graph showing the results of the growth test in skimmed milk of Example 6 is Comparative Example 15.
젖산균은 인간의 구강, 장, 질, 분변 등에 널리 분포한다. 따라서, 이들로부터 젖산균을 분리하여 그 특성을 시험함으로써 원하는 성질을 갖는 젖산균을 획득하는 방법이 행해지고 있으며, 특히 분변으로부터 젖산균을 분리하는 방법이 유용하게 사용되고 있다.Lactic acid bacteria are widely distributed in human oral cavity, intestine, vagina and feces. Therefore, a method of obtaining lactic acid bacteria having desired properties by separating the lactic acid bacteria from these and testing their properties has been performed, and in particular, a method of separating the lactic acid bacteria from feces has been usefully used.
본 발명에서는 숙주 특이성을 고려하여, 한국인을 위한 발효제품에 사용되는 젖산균으로서 한국인의 인체로부터 젖산균을 분리함으로써, 상기한 숙주 특이성의 관계에서 젖산균의 유용한 효과를 극대화할 수 있는 것이다.In the present invention, in consideration of the host specificity, by separating the lactic acid bacteria from the human body of the Korean as a lactic acid bacteria used in fermentation products for Koreans, it is possible to maximize the useful effect of lactic acid bacteria in the relationship of the host specificity.
본 발명자들은 이러한 점을 고려하여 한국인의 생리에 맞는 발효제품을 제조하는데 적합한 균주를 분리하고자 한국 성인들로부터 젖산을 분리하여 시험하던 중, 내산성, 담즙산 내성, 혈중 콜레스테롤 저하능이 우수하고 생장속도가 빠른 새로운 젖산균을 분리하는데 성공하여 본 발명에 도달하였다.In view of this, the present inventors have tested lactic acid from Korean adults to isolate a strain suitable for producing fermentation products suitable for Korean physiology, and have excellent acid resistance, bile acid resistance, blood cholesterol lowering ability and rapid growth rate. Successful isolation of new lactic acid bacteria has reached the present invention.
본 발명에 따른 균주를 분리하기 위하여 건강한 한국인 성인의 분변을 0.02 % 소디움 아지드(sodium azide)가 포함된 엠알에스(MRS) 액체 배지에 넣고 37 ℃에서 24시간 배양하였다. 배양후 10 μ 백금이를 사용하여 배양액을 취하여 다시 0.02 % 소디움 아지드가 포함된 엠알에스 한천 평판배지에 도말하고 37 ℃에서 48 시간동안 배양하였다. 형성된 균락중에서 내산성 및 담즙산 내성을 시험하여 본 발명의 균주를 분리하였다. 본 발명의 젖산균은 1998. 7. 3. 자로 한국종균협회에 기탁되었다(수리번호: KFCC-11041).In order to isolate the strains according to the present invention, feces of healthy Korean adults were placed in MRS liquid medium containing 0.02% sodium azide and incubated at 37 ° C for 24 hours. After incubation, the culture medium was taken using 10 μl platinum, and then plated again on agar plate agar containing 0.02% sodium azide and incubated at 37 ° C. for 48 hours. Among the fungi formed, the strains of the present invention were isolated by testing for acid resistance and bile acid resistance. Lactobacillus of the present invention was deposited on July 3, 1998 by the Korean spawn association (Repair number: KFCC-11041).
본 발명에 따른 젖산균의 특성은 다음과 같다.The characteristics of the lactic acid bacteria according to the present invention are as follows.
1) 균의 형태1) Morphology
엠알에스(MRS) 한천평판배지에서 37 ℃, 2일간 배양했을 때 균의 형태Morphology of bacteria when incubated for 2 days at 37 ° C in agar plate (MRS) agar plate
① 세포의 형태: 간균① Cell Type: Bacillus
② 운동성: 없음② Mobility: None
③ 포자형성능: 없음③ Spore Formation Capacity: None
④ 그람(Gram) 염색: 양성④ Gram staining: positive
2) 균총의 형태2) Form of the flora
엠알에스(MRS) 한천평판배지에서 37 ℃, 2일간 배양했을 때 균총의 형태Morphology of the Bacillus incubated at 37 ° C for 2 days in MRS agar plate
① 형상: 원형① Shape: Round
② 융기: 볼록② uplift: convex
③ 표면: 거침(rough)③ Surface: rough
3)생리적 성질3) physiological properties
① 생육온도: 생장가능 생육온도: 25 ∼ 45 ℃① Growth temperature: Possible growth temperature: 25 ~ 45 ℃
최적 생장온도: 37 ∼ 40 ℃Optimum growth temperature: 37-40 ℃
② 생육 pH: 생장가능 생육 pH: 5.0 ∼ 7.5② Growth pH: Growth possible Growth pH: 5.0 ~ 7.5
최적 pH: 6.0 ∼ 6.5Optimum pH: 6.0 to 6.5
③ 산소에 대한 영향: 통성혐기성③ Effect on oxygen: anaerobic anaerobic
4) 카탈라제: -4) Catalase:-
5) 가스형성여부: -5) Gas formation:-
6) 15 ℃에서 생육: -6) Growth at 15 ℃:-
7) 45 ℃에서 생육: +7) Growth at 45 ℃: +
8) 인돌생산: -8) Indole Production:-
9) 젖산생산: +9) Lactic Acid Production: +
10) Bergey's manual의 당 발효 시험10) Sugar fermentation test of Bergey's manual
아미그달린: -Amigdalin:-
아라비노스: -Arabian:-
셀로비오스: +Cellobiose: +
에스큘린: +Esculin: +
과당: +Fructose: +
갈락토스: +Galactose: +
포도당: +Glucose: +
글루코네이트: -Gluconate:-
유당: +Lactose: +
말토스: +Maltose: +
만니톨: -Mannitol:-
만노스: +Mannose: +
멜레지토스: -Melegitos:-
멜리비오스: -Melibiose:-
라피노스: +Rafinos: +
리보스: -Ribose:-
람노스: -Rhamnose:-
살리신: -Raised:-
소르비톨: -Sorbitol:-
자당: +Sucrose: +
트레할로스: +Trehalose: +
크실로스: -Xylose:-
이와 같은 균의 형태학적, 생리적 및 생장 특성에 근거하여 본 발명의 균주는 락토바실러스 애시도필러스로 동정하였고, 본 발명자들은 이를 락토바실러스 애시도필러스 SNUL 01로 명명하였다.Based on the morphological, physiological and growth characteristics of such bacteria, the strain of the present invention was identified as Lactobacillus ashdophyllus, and the inventors named it Lactobacillus ashdophyllus SNUL 01.
본 발명의 젖산균은 배양물 또는 동결건조된 분말 형태로 제공될 수 있다. 이와 같이 본 발명의 젖산균 자체 또는 본 발명의 균주를 이용하여 당 또는 단백질을 발효시킴으로써 얻어지는 본 발명의 균주가 포함된 배양물은, 한국 성인의 장내에서 생존율과 생장이 우수하여 장내 유해 미생물의 생장 억제 효과가 높은 것으로 확인되었으므로 정장제로 사용하여 장내 정상균총의 유지 또는 유해 미생물 억제 등의 정장 효과를 얻을 수 있다. 특히 널리 식용되는 요구르트나 치즈 등의 발효식품을 본 발명의 균주를 사용하여 제조할 수 있다.Lactic acid bacteria of the present invention may be provided in the form of a culture or lyophilized powder. Thus, the culture containing the strain of the present invention obtained by fermenting the sugar or protein using the lactic acid bacteria of the present invention or the strain of the present invention, excellent survival rate and growth in the intestines of Korean adults, inhibiting the growth of harmful microorganisms in the intestine Since it is confirmed that the effect is high, it can be used as a formal agent to obtain formal effects such as maintenance of normal intestinal flora or suppression of harmful microorganisms. Particularly widely fermented foods such as yogurt and cheese can be prepared using the strain of the present invention.
이하 실시예 및 비교예를 통하여 본 발명을 더욱 상세히 설명한다. 이들 실시예 및 비교예에서 사용된 MRS 배지 및 MRS 한천 평판배지의 조성은 각각 다음 표 1 및 2와 같다.Hereinafter, the present invention will be described in more detail with reference to Examples and Comparative Examples. The composition of the MRS medium and MRS agar plate medium used in these Examples and Comparative Examples are shown in Tables 1 and 2, respectively.
실시예 1: 내산성 시험(1)Example 1: Acid Resistance Test (1)
MRS 액상배지에 0.2% 소디움 티오글리콜레이트(sodium thioglycollate)를 첨가하여 MRS 티오(MRS Thio)배지를 조성하였다. 이 배지에 본 발명의 락토바실러스 애시도필러스 SNUL 01 균주를 접종하여 37 ℃에서 24시간 배양하였다. 이 배양물에 멸균한 1.25 N 염산 용액을 첨가하여 배지를 pH 2로 조절하였다. 배지를 계속해서 37℃에서 배양하면서 30분 간격으로 시료를 채취하였다.0.2% sodium thioglycollate was added to the MRS liquid medium to prepare a MRS Thio medium. The medium was inoculated with the Lactobacillus ashidophilus SNUL 01 strain of the present invention and incubated at 37 ° C for 24 hours. Sterilized 1.25 N hydrochloric acid solution was added to the culture to adjust the medium to pH 2. Samples were taken at 30 minute intervals while the medium was subsequently incubated at 37 ° C.
멸균한 0.1% 펩톤 용액 8.5 ㎖와 0.5 N NaOH 용액 0.5 ㎖의 혼합용액으로 채취한 시료를 중화 및 희석시킨 후, 0.1 % 펩톤 용액 9 ㎖으로 연속 희석하였다. 희석된 시료를 MRS 한천 평판배지에 접종하고 37 ℃에서 2일간 배양하여 형성된 균락수를 세어 생균수를 측정하였다.The sample taken with a mixed solution of 8.5 ml of sterilized 0.1% peptone solution and 0.5 ml of 0.5 N NaOH solution was neutralized and diluted, followed by serial dilution with 9 ml of 0.1% peptone solution. Diluted samples were inoculated into MRS agar plate medium and incubated at 37 ° C. for 2 days to count the number of cells formed to measure viable cells.
비교예 1 및 2: 내산성 시험(1)Comparative Examples 1 and 2: Acid Resistance Test (1)
상기 실시예와 동일한 방법 및 조건으로 공시 균주인 락토바실러스 애시도필러스 145(WIESBY, Germany) 및 락토바실러스 애시도필러스 NCFM (MARSCHALL, USA) 균주의 내산성을 시험하여 비교예 1 및 2로 하였다. 실시예 1, 비교예 1 및 비교예 2의 결과를 도 1에 나타낸다.In the same manner and conditions as in the above Example, Lactobacillus ashdophilus 145 (WIESBY, Germany) and Lactobacillus ashdophilus NCFM (MARSCHALL, USA) strains of the test strains were tested for acid resistance to make Comparative Examples 1 and 2. . The result of Example 1, the comparative example 1, and the comparative example 2 is shown in FIG.
실시예 2: 내산성 시험(2)Example 2: Acid Resistance Test (2)
본 발명의 락토바실러스 애시도필러스 SNUL 01을 MRS 액체배지에 접종하여 37 ℃에서 18시간 배양한 후, 원심분리기를 사용하여 20분간 원심분리(3,000×g)함으로써 균체를 회수하였다. 회수된 균체를 생리적 식염수에 현탁시켜 얻어진 현탁액을 생리적 식염수로 희석하였다.The Lactobacillus ashidophilus SNUL 01 of the present invention was inoculated in a MRS liquid medium and incubated at 37 ° C. for 18 hours, and then the cells were recovered by centrifugation (3,000 × g) for 20 minutes using a centrifuge. The suspension obtained by suspending the recovered cells in physiological saline was diluted with physiological saline.
10 % 염산을 첨가하여 pH를 2로 조절한 0.05 M 멸균 인산완충액을 상기 현탁액에 가하여 10 cfu/㎖가 되도록 하였다. 다시 37℃로 배양하면서, 매시간 균액을 채취하여 희석하고 MRS 한천 평판배지에 접종하고 37℃에서 2일간 배양하여 형성된 균락수를 세어 생균수를 측정하였다.0.05 M sterile phosphate buffer with pH adjusted to 2 by addition of 10% hydrochloric acid was added to the suspension to 10 cfu / ml. While culturing again at 37 ° C., the bacterial solution was collected and diluted every hour, inoculated in MRS agar plate medium, and cultured at 37 ° C. for 2 days to count viable cells.
비교예 3 내지 5: 내산성 시험(2)Comparative Examples 3 to 5: acid resistance test (2)
상기 실시예 2와 동일한 방법 및 조건으로 공시 균주인 락토바실러스 애시도필러스 CH-5(CHR. HANSEN'S LAB., A/S DENMARK), 락토바실러스 애시도필러스 145 및 락토바실러스 애시도필러스 NCFM 균주에 대해 내산성을 시험하여 비교예 3 내지 5로 하였다. 실시예 2, 비교예 3 내지 5의 결과를 도 2에 나타낸다.Lactobacillus ashdophyllus CH-5 (CHR. HANSEN'S LAB., A / S DENMARK), Lactobacillus ashdophilus 145 and Lactobacillus ashdophilus NCFM, which are the disclosed strains in the same manner and conditions as in Example 2 Acid resistance was tested for the strains to make Comparative Examples 3 to 5. The result of Example 2 and Comparative Examples 3-5 is shown in FIG.
실시예 3: 담즙산 내성 시험Example 3: Bile Acid Resistance Test
MRS 액체배지에 옥스갈(oxgall, Difco 제조)을 최종 농도가 0 %, 0.3 %, 및 0.5 %가 되도록 첨가한 후 락토바실러스 애시도필러스 SNUL 01을 1 % 접종하여 37 ℃에서 배양하였다. UV-VISIBLE 스펙트로포토미터( UV-1601, SHIMADZU, Co. Japan)를 사용하여 620 ㎚에서 흡광도를 측정하였다.Oxal (oxgall, manufactured by Difco) was added to the MRS broth so that the final concentration was 0%, 0.3%, and 0.5%, and then inoculated with 1% of Lactobacillus ashidophilus SNUL 01 and incubated at 37 ° C. Absorbance was measured at 620 nm using a UV-VISIBLE spectrophotometer (UV-1601, SHIMADZU, Co. Japan).
비교예 6 내지 8: 담즙산 내성 시험Comparative Examples 6 to 8: Bile Acid Resistance Test
상기 실시예3과 동일한 방법 및 조건으로 공시 균주인 락토바실러스 애시도필러스 CH-5, 락토바실러스 애시도필러스 145 및 락토바실러스 애시도필러스 NCFM 균주에 대해 담즙산 내성을 시험하여 비교예 6 내지 8로 하였다. 실시예 3, 비교예 6 내지 8의 결과를 도 3a 내지 도 3d에 나타낸다.By using the same methods and conditions as in Example 3, Lactobacillus ashdophilus CH-5, Lactobacillus ashdophilus 145 and Lactobacillus ashdophilus NCFM strains were tested for bile acid resistance to Comparative Examples 6 to 8 was set. The results of Example 3 and Comparative Examples 6 to 8 are shown in Figs. 3A to 3D.
실시예 4: 콜레스테롤 제거 능력 시험Example 4: Cholesterol Removal Ability Test
0.3 % 옥스갈(oxgall, Difco)과 0.2 %의 티오콜린산 및 콜레스테롤(Water soluble cholesterol, Sigma, Co., 100㎍/㎖)이 함유된 엠알에스(MRS) 액체배지에 본 발명의 락토바실러스 애시도필러스 SNUL 01을 1 % 접종하였다. 37 ℃에서 24시간 배양한 후 배지내에 남아있는 콜레스테롤의 함량을 루델과 모리스(Rudel & Morris, J. Lipid Research, 1973. 14:364-366)의 방법으로 측정하였다.Lactobacillus ash of the present invention in MRS liquid medium containing 0.3% oxgall (Difco), 0.2% thiocholic acid and cholesterol (Water soluble cholesterol, Sigma, Co., 100 ㎍ / ㎖) Dofilus SNUL 01 was inoculated 1%. After 24 hours of incubation at 37 ℃, the content of cholesterol remaining in the medium was measured by the method of Rudel and Morris (Rudel & Morris, J. Lipid Research, 1973. 14: 364-366).
비교예 9 내지 11Comparative Examples 9 to 11
상기 실시예 4와 동일한 조건 및 방법으로 공시 균주인 락토바실러스 애시도필러스 ATCC 43121, 락토바실러스 애시도필러스 CH-5 및 락토바실러스 애시도필러스 145 균주에 대해 콜레스테롤 제거 능력의 시험을 측정하였다.In the same conditions and methods as in Example 4, the test of cholesterol removal ability was measured for the tested strains Lactobacillus ashidophilus ATCC 43121, Lactobacillus ashidophilus CH-5 and Lactobacillus ashidophilus 145 strains. .
상기 실시예 4와 비교예 9 내지 11의 결과들 다음 표 3에 표시한다.Results of Example 4 and Comparative Examples 9 to 11 are shown in Table 3 below.
실시예 5: MRS 액체배지에서의 생장 시험Example 5: Growth Test in MRS Liquid Medium
멸균된 MRS 액체배지에 본 발명에 따른 락토바실러스 애시도필러스 SNUL 01을 약 106cfu/㎖ 접종하여 37 ℃에서 24시간 배양하였다. 배양 시간의 경과에 따른 생균수의 변화는 희석된 시료를 MRS 한천 평판배지에 접종하고 37℃에서 2일간 배양하여 형성된 균락수를 세어 생균수를 측정하였다.The sterilized MRS liquid medium was inoculated with about 10 6 cfu / mL of Lactobacillus ashidophilus SNUL 01 according to the present invention and incubated at 37 ° C for 24 hours. The change of viable cell number over the cultivation time was measured by inoculating the diluted sample into MRS agar plate medium and incubating at 37 ° C. for 2 days to count the viable cell number.
비교예 12 내지 14Comparative Examples 12 to 14
상기 실시예 5와 동일한 방법 및 조건으로 공시 균주인 락토바실러스 애시도필러스 CH-5, 락토바실러스 애시도필러스 145 및 락토바실러스 애시도필러스 NCFM을 배양한 후 생균수를 측정하였다. 상기 실시예 5 및 비교예 12 내지 14의 결과를 도 4에 나타낸다.The number of viable cells was measured after incubating the strains Lactobacillus ashidophilus CH-5, Lactobacillus ashidophilus 145, and Lactobacillus ashidophilus NCFM in the same manner and in the same manner as in Example 5. The result of Example 5 and Comparative Examples 12-14 is shown in FIG.
실시예 6: 우유에서의 생장 시험Example 6: Growth Test in Milk
12 %의 멸균 환원탈지유에 본 발명의 락토바실러스 애시도필러스 SNUL 01을 1 % 농도로 접종하여 37 ℃에서 24시간 배양하면서 MRS 한천 평판배지에 접종하고 37℃ 에서 2일간 배양하여 형성된 균락수를 세어 생균수를 측정하였다.Inoculated with 12% sterile reduced skim milk at 1% concentration of Lactobacillus ashidophilus SNUL 01 of the present invention and incubated at 37 ° C. for 24 hours while inoculating MRS agar plate medium and incubating at 37 ° C. for 2 days Counting viable cells was measured.
비교예 15 및 16Comparative Examples 15 and 16
상기 실시예 6와 동일한 방법 및 조건으로 공시 균주인 락토바실러스 애시도필러스 CH-5 및 락토바실러스 애시도필러스 NCFM을 배양한 후 생균수를 측정하였다. 상기 실시예 6 및 비교예 15 및 16의 결과를 도 5에 나타낸다.By virtue of the same methods and conditions as in Example 6, Lactobacillus ashidophilus CH-5 and Lactobacillus ashdophilus NCFM were cultured, and the number of viable cells was measured. The result of Example 6 and Comparative Examples 15 and 16 is shown in FIG.
이상의 설명 및 실시예로부터 명백한 바와 같이, 본 발명에 따른 락토바실러스 애시도필러스 SNUL 01은 내산성과 담즙산 내성 및 콜레스테롤 저하능이 높고 생장속도가 빠른 특성이 있다. 따라서, 본 발명의 균주를 포함하는 음식물을 섭취하였을 때 소장에까지 도달하는 젖산균의 생존율이 종래의 균주보다 높으며, 특히 본 발명의 균주는 건강한 한국성인의 생체에서 분리한 것이기 때문에 한국인의 장내 정착할 가능성이 높다.As is apparent from the above description and the examples, the Lactobacillus ashidophilus SNUL 01 according to the present invention has high acid resistance, bile acid resistance, cholesterol lowering ability, and rapid growth rate. Therefore, the survival rate of lactic acid bacteria reaching the small intestine when ingesting the food containing the strain of the present invention is higher than the conventional strain, in particular, because the strain of the present invention is isolated from the living body of healthy Korean adults, the possibility of intestinal settlement of Koreans This is high.
그러므로, 본 발명의 균주 또는 균주를 배양한 배양물이나 발효식품을 식음용하였을 때, 정장 효과 및 콜레스테롤 저하 효과를 기대할 수 있다.Therefore, when the culture or fermented food cultured strain or strain of the present invention can be eaten, it can be expected to have a formal effect and cholesterol lowering effect.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019980027045A KR100299306B1 (en) | 1998-07-06 | 1998-07-06 | Lactic acid bacteria with high acid resistance and growth rate and excellent blood cholesterol lowering ability |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019980027045A KR100299306B1 (en) | 1998-07-06 | 1998-07-06 | Lactic acid bacteria with high acid resistance and growth rate and excellent blood cholesterol lowering ability |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000007623A KR20000007623A (en) | 2000-02-07 |
KR100299306B1 true KR100299306B1 (en) | 2001-11-30 |
Family
ID=19543175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019980027045A KR100299306B1 (en) | 1998-07-06 | 1998-07-06 | Lactic acid bacteria with high acid resistance and growth rate and excellent blood cholesterol lowering ability |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100299306B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100725012B1 (en) | 2005-08-09 | 2007-06-04 | 주식회사한국야쿠르트 | The new lactobacillus acidophilus HY 7036 isolated from korean adult, having high constipation improvement effect, high relieving intestinal disorders and high organic acid producibility, and products containing it |
KR100822038B1 (en) | 2006-11-10 | 2008-04-15 | 건국대학교 산학협력단 | LACTOBACILLUS ACIDOPHILUS A12 HAVING GASTRIC JUICE-RESISTANCE, BILE ACID-RESISTANCE AND PRODUCING INTERLEUKIN 1alpha;AND ITS USE |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI241912B (en) * | 2002-10-30 | 2005-10-21 | Food Industry Res & Dev Inst | Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol |
KR101333758B1 (en) * | 2012-02-10 | 2013-11-28 | 매일유업주식회사 | Lactobacillus plantarum with high acetaldehyde dehydrogenase activity and dairy products, health functional food and food additives comprising the same |
KR101371648B1 (en) * | 2012-02-10 | 2014-03-07 | 매일유업주식회사 | Lactobacillus brevis with high alcohol dehydrogenase activity and dairy products, health functional food and food additives comprising the same |
-
1998
- 1998-07-06 KR KR1019980027045A patent/KR100299306B1/en not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
Kor. J. Appl. Microbiol. Biotechnol.24(3) 304-310 (1996년) * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100725012B1 (en) | 2005-08-09 | 2007-06-04 | 주식회사한국야쿠르트 | The new lactobacillus acidophilus HY 7036 isolated from korean adult, having high constipation improvement effect, high relieving intestinal disorders and high organic acid producibility, and products containing it |
KR100822038B1 (en) | 2006-11-10 | 2008-04-15 | 건국대학교 산학협력단 | LACTOBACILLUS ACIDOPHILUS A12 HAVING GASTRIC JUICE-RESISTANCE, BILE ACID-RESISTANCE AND PRODUCING INTERLEUKIN 1alpha;AND ITS USE |
Also Published As
Publication number | Publication date |
---|---|
KR20000007623A (en) | 2000-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0554418B1 (en) | Intestine colonizing lactobacilli | |
KR102028744B1 (en) | Lactobacillus plantarum HY7717 strain having immune-enhancing activity, antioxidative activity and digestive fluid resistance and use thereof | |
AU2003252888B2 (en) | Acid- and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol | |
US11026983B2 (en) | Bifidobacterium breve CBT BR3 strain for promotion of growth and nutraceutical composition for promotion of growth containing the same | |
EP1743042B1 (en) | Lactic acid bacteria strains exhibiting probiotic properties and compositions comprising the same | |
KR100299306B1 (en) | Lactic acid bacteria with high acid resistance and growth rate and excellent blood cholesterol lowering ability | |
KR20030064030A (en) | Novel probiotic strain isolated from Korean feces having gastric juice-resistance, bile acid-resistance and its use | |
KR100543115B1 (en) | Lactic acid bacteria having high alcohol dehydrogenase and acetaldehyde dehydrogenase activity, and metabolize ethanol and acetaldehyde | |
KR100609779B1 (en) | Lactic acid bacteria degrading alcohol and acetaldehyde | |
KR100240687B1 (en) | Lactobacillus acidophilus ky 2104 and its uses | |
KR100455832B1 (en) | The new lactobacillus plantarum isolated from kimchi, having high resistance ability of acid and bile, and products containing it | |
CN113881592B (en) | Lactobacillus reuteri and application thereof | |
KR100424659B1 (en) | Novel probiotic strain having alcohol-resistance and its use | |
EP4209579A1 (en) | Bifidobacterium inhibiting expression of muscle atrophy gene | |
KR100725012B1 (en) | The new lactobacillus acidophilus HY 7036 isolated from korean adult, having high constipation improvement effect, high relieving intestinal disorders and high organic acid producibility, and products containing it | |
KR20020072807A (en) | Novel lactobacillus sp. strain having the effect of immune enhancement | |
KR100865363B1 (en) | Bifidobacterium infantis MAEIL-K9 strain and health-promoting food containing the same | |
KR0142615B1 (en) | New Lactic Acid Bacteria with Excellent Acid Resistance and Cholesterol Degradation Isolated from Feces of Korean Infant and Their Use | |
KR101726207B1 (en) | --glucosidase LT19-2 [KCTC18497P]Novel Bifidobacterium animalis LT19-2 strain[KCTC18497P] having excellent -glucosidase activity | |
KR100786364B1 (en) | Novel strains of lactobacillus paracasei subsp. paracasei bfi46 and lactobacillus paracasei subsp. paracasei afj88 having immunoactivity | |
KR100808956B1 (en) | Lactic acid bacteria separated from kimchi and exopolysaccharides produced thereby | |
KR0157757B1 (en) | Separation method for bifidobacterium which has acid tolerance | |
KR100316517B1 (en) | The new lactobacillus acidophilus isolated from korean adult feces, having high acid producibility, and products containing it | |
KR100533677B1 (en) | Feed additive for fish-breeding containing Lactobacillus plantarum as effective ingradient | |
KR100804193B1 (en) | A novel strain of lactobacillus acidophilus LA-12 produced lactase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130604 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20140602 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20150608 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20160601 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20170607 Year of fee payment: 17 |
|
FPAY | Annual fee payment |
Payment date: 20180604 Year of fee payment: 18 |
|
EXPY | Expiration of term |